Stockscreener 앱 받기
2.51
2.03%
0.05
China Sxt Pharmaceuticals Inc 주식(SXTC)의 최신 뉴스
China SXT (SXTC) registers 157.5M-share resale linked to $31.5M pre-paid facility - Stock Titan
China SXT Pharmaceuticals Secures Up to $30 Million in New Pre‑Paid Share Financing - TipRanks
China SXT Pharmaceuticals (NASDAQ: SXTC) agrees to up to $30M pre-paid share facility - Stock Titan
China SXT (NASDAQ: SXTC) 20-F outlines VIE, dual-class shares and China risk - Stock Titan
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Enterprise value to EBITDA forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to sales forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to revenue forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to book forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Price to earnings forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
Enterprise value to EBIT forward of China SXT Pharmaceuticals, Inc. – NASDAQ:SXTC - TradingView
China SXT Pharmaceuticals Inc (SXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
China SXT Pharmaceuticals (SXTC) Consolidates Near Resistance After Modest GainGEX Level - dars.gov.et
China SXT Pharmaceuticals Inc (SXTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
China SXT Pharmaceuticals Inc - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Institutional Confidence - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
China SXT Pharmaceuticals Inc (SXTC) Valuation: PE, PB & Fair Value Analysis - TradingKey
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
China SXT Pharmaceuticals shares surge over 25% after hours: Here's why - MSN
China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities - The Globe and Mail
China SXT Pharmaceuticals (SXTC) launches $100M ATM offering with Univest - Stock Titan
China SXT (NASDAQ: SXTC) sets up $100M at-the-market share offering - Stock Titan
SXTCChina SXT Pharmaceuticals Inc Latest SEC Filings - Finviz
China SXT Pharmaceuticals (SXTC) Surges 7%: Potential Breakout Above ResistanceTriple MA Cross - newsline.com
China SXT Pharmaceuticals (SXTC) Slips 3% as Stock Tests Key Support LevelsDip Buy Trade - dars.gov.et
SXTC Faces Selling Pressure: Key Levels to Watch After 7.3% DeclineStraddle Setup - newsline.com
China SXT Pharmaceuticals (SXTC) Sees Uptick Amid Support HoldingVolume Rate Change - Newser
SXTC Should I Buy - Intellectia AI
TradingKey - TradingKey
SXTC Technical Analysis | Trend, Signals & Chart Patterns | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement - The Globe and Mail
China SXT Pharmaceuticals Inc (SXTC) - MSN
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
MSN Money - MSN
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
What guidance trend China SXT (SXTC)? (Bearish Momentum) 2026-04-29Volume Breakout - newser.com
China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake - Stock Titan
China SXT Pharmaceuticals (SXTC) CFO listed as insider in Form 3 - Stock Titan
China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3 - Stock Titan
Director Ji Xiaodong files Form 3 for China SXT (SXTC) - Stock Titan
Director Liu Tong Tony files Form 3 at China SXT (SXTC) - Stock Titan
Co-CEO Simon Lim listed in China SXT (SXTC) Form 3 with no trades - Stock Titan
[Form 3] China SXT Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan
China SXT (SXTC) Sector Leadership | Q1 2025: Earnings ReportCommunity Sell Signals - Xã Thanh Hà
China SXT (SXTC) Stock: Why Industry Position (Bullish Sentiment) 2026-04-22Cash Flow - Cổng thông tin điện tử tỉnh Lào Cai
China SXT (SXTC) Stock Days to Cover (Smart Money Exits) 2026-04-15Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
China SXT Pharmaceuticals Raises $760,000 in Registered Share Offering - The Globe and Mail
1.73%
0.23%
자본화:
|
볼륨(24시간):